Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Independence Blue Cross | Screening for Vertebral Fracture with Dual-Energy X-ray Absorptiometry (DEXA/DXA)PayerPolicy · IBX-COMMERCIAL-09-00-40 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | School-Based Outpatient Behavioral Health Services in a School SettingPayerPolicy · IBX-COMMERCIAL-14-00-04 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Scar RevisionPayerPolicy · IBX-COMMERCIAL-11-08-25 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)PayerPolicy · IBX-COMMERCIAL-07-13-06 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Sacral Nerve Stimulation (SNS) and Posterior Tibial Nerve Stimulation (PTNS) for the Control of IncontinencePayerPolicy · IBX-COMMERCIAL-11-17-04 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Sacituzumab govitecan-hziy (Trodelvy)PayerPolicy · IBX-COMMERCIAL-08-01-60 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Rozanolixizumab-noli (Rystiggo)PayerPolicy · IBX-COMMERCIAL-08-02-08 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Routine Foot Care for Certain Medical ConditionsPayerPolicy · IBX-COMMERCIAL-07-07-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Routine Costs Associated with Qualifying Clinical TrialsPayerPolicy · IBX-COMMERCIAL-07-00-20 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Routine/Non-routine VaccinesPayerPolicy · IBX-COMMERCIAL-08-01-04AJ-C0133A4CD9 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Rituximab (Rituxan) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela)PayerPolicy · IBX-COMMERCIAL-08-00-50AF-C912D250F8 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Risankizumab-rzaa (Skyrizi) for Intravenous UsePayerPolicy · IBX-COMMERCIAL-08-01-95 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Rhytidectomy and/or Cervicoplasty With or Without Liposuction and/or PlatysmaplastyPayerPolicy · IBX-COMMERCIAL-11-08-13 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Revakinagene taroretcel-lwey (Encelto)PayerPolicy · IBX-COMMERCIAL-08-02-44 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Retifanlimab-dlwr (Zynyz)PayerPolicy · IBX-COMMERCIAL-08-02-05 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Repository Corticotropin Injection (Acthar Gel, Purified Cortrophin Gel)PayerPolicy · IBX-COMMERCIAL-08-01-12 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reporting Requirements for Drugs and BiologicsPayerPolicy · IBX-COMMERCIAL-00-01-49 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reporting and Documentation Requirements for Anesthesia ServicesPayerPolicy · IBX-COMMERCIAL-00-01-14 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Repair or Replacement of an External Prosthetic DevicePayerPolicy · IBX-COMMERCIAL-05-00-45 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Repair of Cleft Lip, Cleft Nose, and/or Cleft PalatePayerPolicy · IBX-COMMERCIAL-11-03-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Repair and Replacement of Durable Medical Equipment (DME) and Prosthetic DevicesPayerPolicy · IBX-COMMERCIAL-05-00-44 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Renal Denervation for Uncontrolled HypertensionPayerPolicy · IBX-COMMERCIAL-11-02-29 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Removal of Breast ImplantsPayerPolicy · IBX-COMMERCIAL-11-08-14 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Remote Electrical Neuromodulation for MigrainesPayerPolicy · IBX-COMMERCIAL-05-00-86 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement of Surgical Pathology Services for Prostate BiopsyPayerPolicy · IBX-COMMERCIAL-00-01-73 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for the Administration of ImmunizationsPayerPolicy · IBX-COMMERCIAL-07-00-15 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for the Administration of Drugs, Substances, and/or Biologic AgentsPayerPolicy · IBX-COMMERCIAL-00-10-43 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for Radiopharmaceutical AgentsPayerPolicy · IBX-COMMERCIAL-09-00-32AL-9B54531E0C | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for Outpatient Emergency Department VisitsPayerPolicy · IBX-COMMERCIAL-00-10-03 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for Components of Comprehensive Laboratory PanelsPayerPolicy · IBX-COMMERCIAL-00-01-61 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for Certain Evaluation and Management (E/M) ServicesPayerPolicy · IBX-COMMERCIAL-00-01-69 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for Associated Services Performed in Conjunction with Dental CarePayerPolicy · IBX-COMMERCIAL-00-01-18 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement for an Intraocular LensPayerPolicy · IBX-COMMERCIAL-11-05-10 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reimbursement For Advanced Practice Provider ServicesPayerPolicy · IBX-COMMERCIAL-00-10-45 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Refractive Keratoplasty, Keratoprosthesis, and Corneal Collagen Cross-LinkingPayerPolicy · IBX-COMMERCIAL-11-05-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reduction MammoplastyPayerPolicy · IBX-COMMERCIAL-11-08-02 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Reconstructive Breast Surgery and Post-Mastectomy ProsthesesPayerPolicy · IBX-COMMERCIAL-11-08-15AD-E5C9A7561F | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Rapid Whole Exome Sequencing (rWES) and Rapid Whole Genome Sequencing (rWGS) for Diagnosis of Genetic DisordersPayerPolicy · IBX-COMMERCIAL-06-02-46 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Ramucirumab (Cyramza)PayerPolicy · IBX-COMMERCIAL-08-01-25 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Radium Ra 223 dichloride (Xofigo) Injection (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-08-01-14 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Radiologic Guidance and/or Supervision and Interpretation of a ProcedurePayerPolicy · IBX-COMMERCIAL-00-10-36 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Radioembolization for Primary and Metastatic Tumors of the Liver (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-09-00-48 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Radiation Therapy Services (Independence)PayerPolicy · IBX-COMMERCIAL-09-00-56 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pulse Oximetry Devices in the Home SettingPayerPolicy · IBX-COMMERCIAL-05-00-31 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Pulmonary RehabilitationPayerPolicy · IBX-COMMERCIAL-10-04-01 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Psychological TestingPayerPolicy · IBX-COMMERCIAL-14-00-02 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Psychiatric Collaborative Care Management (CoCM)PayerPolicy · IBX-COMMERCIAL-00-01-70 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Proton Beam Radiation Therapy (Independence Administrators)PayerPolicy · IBX-COMMERCIAL-09-00-49 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Proteomic (Protein)-Based Testing for the Evaluation of Ovarian (Adnexal) Masses Using OVA1 Test and Risk of Ovarian Malignancy Algorithm (ROMA)PayerPolicy · IBX-COMMERCIAL-06-02-43 | New policy |
|---|
| Aug 2, 2026 | Independence Blue Cross | Protein Biomarkers for the Diagnosis and Cancer Risk Assessment of Prostate CancerPayerPolicy · IBX-COMMERCIAL-06-02-53 | New policy |
|---|